Fluoranthene derivatives
    4.
    发明授权
    Fluoranthene derivatives 失效
    荧蒽衍生物

    公开(公告)号:US4808632A

    公开(公告)日:1989-02-28

    申请号:US79352

    申请日:1987-07-30

    申请人: Kenneth W. Bair

    发明人: Kenneth W. Bair

    IPC分类号: C07C215/10

    摘要: The present invention relates to compounds of formula (I)ArCH.sub.2 R.sup.1 (I)or a monomethyl or a monoethyl ether thereof (the compound of formula (I) including these ethers may contain no more than 30 carbon atoms in total); ethers, esters thereof; acid addition salts thereof; wherein Ar is a fluoranthene or substituted fluoranthene ring system; R.sup.1 contains not more than eight carbon atoms and is a group ##STR1## wherein m is 0 or 1; R.sup.5 is hydrogen;R.sup.6 and R.sup.7 are the same or different and each is hydrogen or C.sub.1-3 alkyl optionally substituted by hydroxy;R.sup.8 and R.sup.9 are the same or different and each is hydrogen or C.sub.1-3 alkyl; ##STR2## is a five- or six-membered saturated carbocyclic ring; R.sup.10 is hydrogen, methyl or hydroxymethyl;R.sup.11, R.sup.12 and R.sup.13 are the same or different and each is hydrogen or methyl;R.sup.14 is hydrogen, methyl, hydroxy, or hydroxymethyl.

    摘要翻译: 本发明涉及式(I)化合物,其中ArCH 2 R 1(I)或其单甲醚或单乙醚(包括这些醚的式(I)化合物总共可含有不超过30个碳原子); 醚,酯; 其酸加成盐; 其中Ar是荧蒽或取代的荧蒽环体系; R1含有不多于8个碳原子,并且是一个基团,其中m是0或1; R5是氢; R6和R7相同或不同,各自为氢或任选被羟基取代的C 1-3烷基; R 8和R 9相同或不同,各自为氢或C 1-3烷基; 一个五元或六元饱和碳环; R 10是氢,甲基或羟甲基; R11,R12和R13相同或不同,各自为氢或甲基; R14是氢,甲基,羟基或羟甲基。

    Cycloalkane-indene-carboximidamide derivatives
    10.
    发明授权
    Cycloalkane-indene-carboximidamide derivatives 失效
    环烷 - 茚 - 亚甲基脒衍生物

    公开(公告)号:US4661522A

    公开(公告)日:1987-04-28

    申请号:US734049

    申请日:1985-05-15

    申请人: Tom Beetz

    发明人: Tom Beetz

    摘要: The present invention is dealing with cycloalkane-indene-carboximidamide derivatives having the general formula: ##STR1## wherein Rx together with either Ry.sub.1 or Ry.sub.2 represent the moiety ##STR2## (the other Ry being hydrogen), n represents the number 1, 2 or 3,R represents hydrogen or a (1-4 C)-alkyl group,R.sub.1 represents hydrogen, (1-4 C)-alkyl, hydroxyl, (1-4 C)-alkoxy or an amino group which is unsubstituted or substituted by (1-4 C)-alkyl andR.sub.2 is hydrogen, hydroxyl or (1-4 C)-alkyl, as well as the pharmaceutically acceptable salts thereof, with powerful blood platelet aggregation-inhibiting activity.

    摘要翻译: 本发明涉及具有以下通式的环烷 - 茚 - 肟基亚胺酰胺衍生物:其中Rx与Ry1或Ry2一起代表部分(另一个Ry是氢),n代表数字1,2或 3,R表示氢或(1-4C) - 烷基,R1表示氢,(1-4C) - 烷基,羟基,(1-4C) - 烷氧基或未取代或被 (1-4C) - 烷基和R2是氢,羟基或(1-4C) - 烷基,以及其药学上可接受的盐,具有强大的血小板聚集抑制活性。